Recruiting
Phase 2

Converting HR+ Breast Cancer Into an Individualized Vaccine

Sponsor:

Weill Medical College of Cornell University

Code:

NCT03804944

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Focal Radiation therapy

Pembrolizumab (200mg IV for 30 minutes

CDX-301

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information